Nascent Pharma Holdings Statistics
Total Valuation
NASC has a market cap or net worth of 2.03 million.
| Market Cap | 2.03M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NASC has 135.98 million shares outstanding.
| Current Share Class | 135.98M |
| Shares Outstanding | 135.98M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +19.78% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.11% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.97 |
| PB Ratio | -0.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 8.25 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.14
| Current Ratio | 0.14 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -62.52% |
| Return on Invested Capital (ROIC) | -113.42% |
| Return on Capital Employed (ROCE) | 76.31% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 86,128 |
| Profits Per Employee | -1.10M |
| Employee Count | 12 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 2.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.86, so NASC's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 50.96 |
| Average Volume (20 Days) | 23,483 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.38 |
Income Statement
In the last 12 months, NASC had revenue of 1.03 million and -13.26 million in losses. Loss per share was -0.29.
| Revenue | 1.03M |
| Gross Profit | -343,305 |
| Operating Income | -7.47M |
| Pretax Income | -13.26M |
| Net Income | -13.26M |
| EBITDA | -6.78M |
| EBIT | -7.47M |
| Loss Per Share | -0.29 |
Balance Sheet
The company has 7,879 in cash and 9.01 million in debt, with a net cash position of -9.01 million or -0.07 per share.
| Cash & Cash Equivalents | 7,879 |
| Total Debt | 9.01M |
| Net Cash | -9.01M |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | -9.79M |
| Book Value Per Share | -0.26 |
| Working Capital | -10.05M |
Cash Flow
| Operating Cash Flow | 246,464 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 693,641 |
| Net Borrowing | -259,935 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -33.22% |
| Operating Margin | -722.63% |
| Pretax Margin | -1,282.82% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NASC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -608.91% |
| Shareholder Yield | -608.91% |
| Earnings Yield | -652.18% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 14, 2022. It was a reverse split with a ratio of 0.0666667.
| Last Split Date | Feb 14, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0666667 |
Scores
NASC has an Altman Z-Score of -105.08 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -105.08 |
| Piotroski F-Score | 3 |